Clinical Trials Browser

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT03875781 2026-01-15

NORAD01

Phase 3 Recruiting

540 enrolled

Gastrointestinal

Rectal Neoplasms

NCT06899126 2026-01-08

DESTINY-Lung06

Phase 3 Recruiting

686 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03570892 2026-01-06

BELINDA

Phase 3 Active not recruiting

331 enrolled 10 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05717166 2025-12-31

SABR-SYNC

Phase 3 Recruiting

180 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07306663 2025-12-29

ESO-Nanjing7

Phase 3 Active not recruiting

242 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02314182 2025-12-19

GRECCAR8

Phase 3 Completed

5 enrolled

Gastrointestinal

Rectal Neoplasms

Clinical Trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

QuANTUM-WILD

NIRVANA-LUNG

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

TroFuse-031

CHIC-STS01

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

TD-NEOE3V3

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NORAD01

DESTINY-Lung06

BELINDA

SABR-SYNC

ESO-Nanjing7

GRECCAR8